SILO PHARMA, INC. Shareholders' Equity
SILO PHARMA, INC. (SILO) had Shareholders' Equity of $4.89 million as of 2026-06-30, per its 10-Q filed 2026-08-13.
Financial Statements › Balance Sheet › Equity › Equity, Attributable to Parent
us-gaap:StockholdersEquity · last filed 2026-08-13
- 2026-06-30: Stockholders' Equity Attributable to Parent $4.89M.
- 2026-03-31: Stockholders' Equity Attributable to Parent $5.68M.
- 2025-12-31: Stockholders' Equity Attributable to Parent $6.31M.
- 2025-09-30: Stockholders' Equity Attributable to Parent $5.01M.
| Period end | Stockholders' Equity Attributable to Parent | Stockholders' Equity Attributable to Parent as first filed |
|---|---|---|
| 2026-06-30 | $4.89M 10-Q · filed 2026-08-13 | |
| 2026-03-31 | $5.68M 10-Q · filed 2026-08-13 | |
| 2025-12-31 | $6.31M 10-Q · filed 2026-08-13 | |
| 2025-09-30 | $5.01M 10-Q · filed 2025-11-13 | |
| 2025-06-30 | $4.92M 10-Q · filed 2026-08-13 | |
| 2025-03-31 | $4.01M 10-Q · filed 2026-08-13 | |
| 2024-12-31 | $5.03M 10-Q · filed 2026-08-13 | |
| 2024-09-30 | $6.78M 10-Q · filed 2025-11-13 | |
| 2024-06-30 | $5.96M 10-Q · filed 2025-11-13 | |
| 2024-03-31 | $5.29M 10-Q · filed 2025-11-13 | |
| 2023-12-31 | $6.18M POS AM · filed 2026-04-14 | |
| 2023-09-30 | $7.50M 10-Q · filed 2024-11-12 | |
| 2023-06-30 | $8.30M 10-Q · filed 2024-11-12 | |
| 2023-03-31 | $9.44M 10-Q · filed 2024-11-12 | |
| 2022-12-31 | $10.34M 10-K · filed 2025-03-28 | |
| 2022-09-30 | $11.85M 10-Q · filed 2023-11-13 | |
| 2022-06-30 | $7.87M 10-Q · filed 2023-11-13 | |
| 2022-03-31 | $8.50M 10-Q · filed 2023-11-13 | |
| 2021-12-31 | $9.06M 10-K · filed 2024-03-25 | |
| 2021-09-30 | $10.15M 10-Q · filed 2022-11-10 | |
| 2021-06-30 | $3.77M 10-Q · filed 2022-11-10 | |
| 2021-03-31 | $4.23M 10-Q · filed 2022-11-10 | |
| 2020-12-31 | $1.28M 10-K · filed 2023-03-24 | |
| 2020-09-30 | $2.07M 10-Q · filed 2020-11-05 | |
| 2020-06-30 | $2.30M 10-Q · filed 2020-11-05 | |
| 2020-03-31 | -$261.50K 10-Q · filed 2021-05-17 | -$261.77K 10-Q · filed 2020-05-12 |
| 2019-12-31 | -$22.89K 10-K · filed 2022-03-28 | |
| 2019-09-30 | -$101.30K 10-Q · filed 2020-11-05 | |
| 2019-06-30 | $102.94K 10-Q · filed 2020-11-05 | |
| 2019-03-31 | $292.67K 10-Q · filed 2020-11-05 | |
| 2018-12-31 | $407.44K 10-K/A · filed 2021-05-17 | |
| 2018-09-30 | $1.01M 10-Q · filed 2019-11-13 | |
| 2018-06-30 | $904.68K 10-Q · filed 2019-11-13 | |
| 2018-03-31 | $1.22M 10-Q · filed 2019-11-13 | |
| 2017-12-31 | $1.20M 10-K · filed 2020-03-20 | |
| 2017-09-30 | $996.16K 10-Q · filed 2018-11-14 | |
| 2016-12-31 | $846.51K 10-K · filed 2019-04-04 | |
| 2013-12-31 | $1.79M 10-K · filed 2014-03-31 | |
| 2013-09-30 | $543.62K 10-Q · filed 2013-11-14 | |
| 2013-06-30 | $333.45K 10-Q · filed 2013-08-08 | |
| 2013-03-31 | -$44.08K 10-Q · filed 2013-05-15 | |
| 2012-12-31 | -$41.19K 10-K · filed 2014-03-31 | |
| 2011-12-31 | -$1.75K 10-K · filed 2014-03-31 | |
| 2010-12-31 | $47.48K 10-K · filed 2014-03-31 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Genprex, Inc. (GNPX) | United States | $0.003B | -0.02 |
| Alaunos Therapeutics, Inc. (TCRT) | United States | $0.003B | -1.44 |
| GeoVax Labs, Inc. (GOVX) | United States | $0.003B | -0.45 |
| Petros Pharmaceuticals, Inc. (PTPI) | United States | $0.003B | |
| Sunshine Biopharma Inc. (SBFM) | $0.003B | ||
| Matinas BioPharma Holdings, Inc. (MTNB) | United States | $0.003B | |
| ZyVersa Therapeutics, Inc. (ZVSA) | United States | $0.002B | |
| Aptevo Therapeutics Inc. (APVO) | United States | $0.003B | |
| BioXcel Therapeutics, Inc. (BTAI) | United States | $0.002B | |
| JUPITER NEUROSCIENCES, INC. (JUNS) | United States | $0.002B | -0.02 |